
Peptides et Protéines
3146 produits trouvés pour "Peptides et Protéines"
(1R,3S)-Camphoric Acid
CAS :Applications (1R,3S)-Camphoric Acid is used primarily as a reagent in syntheses of crystalline structures. It is used in the preparation of polymeric transition metal dipyridylamine D-camphorate complexes.
References Blake, K. et al.: Crys. Growth Des., 12, 5215 (2012);Formule :C10H16O4Couleur et forme :White SolidMasse moléculaire :200.235-Oxo-DL-proline-d5
CAS :Produit contrôléApplications 5-Oxo-DL-proline-d5 is a labelled cyclized derivative of L-Glutamic Acid (G596960). The pyroglutamate core has potential application for synthesis of novel anti-bacterials.
References Mischo A. et al.: ChemBioChem., 13, 1421 (2012); Angelov P. et al.: Org. Biomol. Chem.: 10, 3472 (2012);Formule :C52H5H2NO3Couleur et forme :NeatMasse moléculaire :134.14Cyclosporin C
CAS :Produit contrôléApplications A group of nonpolar cyclic oligopeptides with immunosupppressant activity.
References van Wartburg, A., et al.: Prog. Med. Chem., 25, 1 (1988), Jorgensen, K.A., et al.: Scand. J. Imunol., 57, 93 (2003), Vollenbroeker, et al.: Transplant. Proc., 37, 1741 (2005),Formule :C62H111N11O13Degré de pureté :>80%Couleur et forme :NeatMasse moléculaire :1218.61(S)-Lisinopril Dimer
CAS :Produit contrôléApplications (S)-Lisinopril (L468985) impurity. Lisinopril Impurity G (Dimer Impurity)
Formule :C42H60N6O9Couleur et forme :WhiteMasse moléculaire :792.96GSK1904529A
CAS :GSK1904529A (GSK 4529) is a specific inhibitor of IGF-1R (IC50=27 nM) and IR(IC50=25 nM) .Formule :C44H47F2N9O5SDegré de pureté :98.2% - 99.76%Couleur et forme :SolidMasse moléculaire :851.96Liraglutide
CAS :Produit contrôléFormule :C172H265N43O51Couleur et forme :Off-WhiteMasse moléculaire :3751.2(1R,2R)-Bortezomib
CAS :Impurity Bortezomib USP Related Compound A
Applications (1R,2R)-Bortezomib is a diastereomer of Bortezomib (B675700), the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells. Targets the ubiquitin-proteasome pathway
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005); Drahl C.: Chem. and Eng. News, 87, 41 (2009)Formule :C19H25BN4O4Degré de pureté :>85%Couleur et forme :NeatMasse moléculaire :384.245-9-Leuprolide xTFA Salt
CAS :Produit contrôléApplications 5-9-Leuprolide is a metabolite of Leuprolide (L330590), a gonadotropin-releasing hormone (GnRH) analogue acting as an agonist at pituitary GnRH receptors.
References Handelsman, David J., et al.: J. of Steroid Biochem. and Mol. Bio., 141, 113-120 (2014);Okada, Hiroaki, et al.: Pharma. Res., 8(6), 787-91 (1991)Formule :C34H57N9O6·x(C2HF3O2)Couleur et forme :NeatMasse moléculaire :801.9Protoporphyrin-9
CAS :Stability Light Sensitive
Applications Protoporphyrin-9 is the precursor to heme sites and chlorophyll.Formule :C34H34N4O4Couleur et forme :NeatMasse moléculaire :562.66L-Thioproline
CAS :Applications L-Thioproline is used to create a monolayer on gold electrodes for the determination Copper(II). L-Thioproline has shown to be an effect inhibitor of proline absorption in Saccharomyces chevalieri.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Cui, X., et. al.: Sci. China Chem., 53, 257 (2010); Magana-Schwenchke, N., Schwencke, J.: BBA-Biomembranes, 173, 313 (1969)Formule :C4H7NO2SCouleur et forme :NeatMasse moléculaire :133.17Desisobutyl-n-butyl Bortezomib
CAS :Impurity Bortezomib N-Pentyl Impurity
Applications Desisobutyl-n-butyl Bortezomib is an impurity of Bortezomib (B675700). Bortezomib impurity 5.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Lin, G., et al.: J. Biol. Chem., 283, 34423 (2008);Formule :C19H25BN4O4Couleur et forme :NeatMasse moléculaire :384.24L-Valine-d8
CAS :Produit contrôléApplications Labelled analogue of L-Vailne. L-Valine is an essential amino acid and one of 20 proteinogenic amino acids. L-Valine cannot be manufactured by the body and must be acquired through diet or supplementation. L-valine is found in grains, dairy products, mushrooms, meats, peanuts and soy proteins. L-Valine has been used in studies to attenuate arrhythmias and induce hypotensive effects.
References Choi, C.W. et al.: Anim. Feed Sci. Technol., 102, 15 (2002); Kolarski, D. et al.: Krmiva, 30, 155 (1988); Oba, M. et al.: J. Dairy Sci., 93, 2044 (2010); Mitrega, K. et al.: Pharmacol. Res., 64, 218 (2011);Formule :C52H8H3NO2Couleur et forme :NeatMasse moléculaire :125.2N-Pyrazinylcarbonyl-L-phenylalanine Methyl Ester
CAS :Applications Used for the synthesis of Bortezomib from L-phenylalanine via dipeptidyl boronic acid ester intermediates.
References Zhu, Y., et al.: J. Med. Chem., 52, 4192 (2009),Formule :C15H15N3O3Couleur et forme :NeatMasse moléculaire :285.3Lisinopril (S,S,R)-Diketopiperazine (~90%)
CAS :Impurity Lisinopril EP Impurity D
Stability Hygroscopic
Applications Lisinopril (S,S,R)-Diketopiperazine (Lisinopril EP Impurity D) is an impurity of Lisinopril (L468985), an orally active angiotensin-converting enzyme (ACE) inhibitor (1).
References 1. Goa, K. et al.: Drugs. 1996 Oct;52(4):564-88.Formule :C21H29N3O4Degré de pureté :~90%Couleur et forme :White To Off-WhiteMasse moléculaire :387.47β-Hydroxy Thyroxine (>90%)
CAS :Produit contrôléImpurity Levothyroxine beta-Hydroxy Impurity / Levothyroxine beta-Hydroxy T4 Impurity
Applications It has been prepared for testing as possible antithyroid. It showed some thyromimetic activity.
References Wawzone, S., et al.: J. Med. Chem., 6, 442 (1963),Formule :C15H11I4NO5Degré de pureté :>90%Couleur et forme :NeatMasse moléculaire :792.87Bestatin
CAS :Bestatin (Ubenimex) competitively inhibits many aminopeptidases. Bestatin is a microbial metabolite and dipeptide with immunomodulatory and antitumor effects.Formule :C16H24N2O4Degré de pureté :98% - 99.63%Couleur et forme :White Crystalline PowderMasse moléculaire :308.37Ref: TM-T1257
2mg34,00€5mg52,00€10mg64,00€25mg99,00€50mg157,00€100mg222,00€200mg330,00€1mL*10mM (DMSO)58,00€Sugammadex Sodium
CAS :Formule :C72H104O48S8·8NaCouleur et forme :White To BeigeMasse moléculaire :2178.00(R)-Lisinopril Sodium Salt
CAS :Applications R,S,S-Isomer of Lisinopril (L468985).
References Goa, K.L., et al.: Drugs, 52, 564 (1996), Chaturvedi, N., et al.: Lancet, 351, 28 (1998)Formule :C21H31N3NaO5Couleur et forme :NeatMasse moléculaire :428.48(2R,4R)-Sacubitril
CAS :Applications (2R,4R)-Sacubitril is an impurity of Sacubitril (S080895) which is an antihypertensive drug used in combination with valsartan.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References McMurray, J., et al.: N. Eng. J. Med., 371 (2014);Formule :C24H29NO5Couleur et forme :NeatMasse moléculaire :411.491rhPTH (1-30) Trifluoroacetic Acid Salt Hydrate
Produit contrôléImpurity Teriparatide Impurity
Applications A fragment of human parathyroid hormone (hPTH) peptide sequence containing the 30 N-terminal residues of hPTH.
References Niall, et al.: Proc. Natl. Acad. Sci., 71, 384 (1974);Formule :C157H260N48O46S2•x(C2HF3O2)•y(H2O)Couleur et forme :NeatMasse moléculaire :3620.171140218Sacubitril Calcium
CAS :Applications Sacubitril is an antihypertensive drug used in combination with valsartan. The combination drug, valsartan/sacubitril, known during trials as LCZ696 and marketed under the brand name, Entresto, is a treatment for heart failure.
References McMurray, J., et al.: N. Eng. J. Med., 371 (2014)Formule :C24H28NOCa2Couleur et forme :NeatMasse moléculaire :430.524-Methylbenzenesulfonic Acid Monohydrate
CAS :Produit contrôléImpurity Lisinopril EP Impurity B/ Anastrozole EP Impurity F
Applications 4-Methylbenzenesulfonic Acid Monohydrate (Lisinopril EP Impurity B) is used in the synthesis of resveratrol. Also used in the synthesis of oxane derivatives as antimalarial agents.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Davis, M. et al.: Org. Prep. Proc. Int., 45, 304 (2013); Wang, X. et al.: J. Med. Chem., 56, 2547 (2013);Formule :C7H8O3S·H2OCouleur et forme :WhiteMasse moléculaire :190.223,3',5'-Triiodo-L-thyronine
CAS :Formule :C15H12I3NO4Couleur et forme :Light Beige To GreyMasse moléculaire :650.976-Perdeoxy-6-perchloro-γ-cyclodextrin, >90%
CAS :Formule :C48H72Cl8O32Degré de pureté :>90%Couleur et forme :NeatMasse moléculaire :1444.69Dihydro Cyclosporin A
CAS :Produit contrôléApplications A Cyclosporin A (C988900) analog, an immunosuppressant.
References Emmer, G., et al.: J. Med. Chem., 37, 1918 (1994), High, K., et al.: J. Biol. Chem., 269, 9105 (1994),Formule :C62H113N11O12Couleur et forme :WhiteMasse moléculaire :1204.63Bivalirudin Trifluoroacetic Acid Salt
CAS :Applications Bivalirudin Trifluoroacetic Acid Salt is an anticoagulant drug that is a direct thrombin inhibitor. It is used for treatment of acute coronary syndromes, and is a safer alternative to heparin due to lower rates of bleeding as an adverse effect of anticoagulant in patients.
References Stone, G., et al.: N. Engl. J. Med, 355, 2203 (2006); Stone, G., et al.: N Engl J Med, 358, 2218 (2008);Formule :C98H138N24O33·(C2HF3O2)xCouleur et forme :NeatMasse moléculaire :2180.2911402L-Methionine-34S
CAS :Applications Labelled L-Methionine, an essential aminoacid for human development. Hepatoprotectant; antidote (acetominophen poisoning); urinary acidifier.
References Benevenga, N.J., et al.: J. Agric. Food Chem., 22, 2 (1974), Fleisher, L.D., et al.: Clin. Endocrinol. Metab., 3, 37 (1974), Meinnel, T., et al.: Biochimie, 75, 1061 (1993),Formule :C5H11NO234SCouleur et forme :NeatMasse moléculaire :151.11L-Carnitine-L-tartrate
CAS :Produit contrôléApplications L-Carnitine-L-tartrate (cas# 36687-82-8) is a useful research chemical.
Formule :C7H16NO3·C4H4O6Couleur et forme :White To Off-WhiteMasse moléculaire :472.48N-Acetyl-L-carnosine
CAS :Produit contrôléApplications Used in the treatment of cataracts and in the treatment of UV-induced immunosuppression. May act with with lipoic acid (L468725) to reverse age-related metabolic decline and also the indicies of oxidative stress.
References Babizhayev, M., et al.: J. Pharmacol. Toxicol., 1, 201 (2006), Min, J., et al.: J. Neurosci. Res., 86, 2984 (2008), Babizhayev, M., et al.: J. Drug Target., 17, 36 (2009); Hagen et. al, PNAS 99: 1870 (2002); Liu et. al, PNAS 99, 2356 (2002)Formule :C11H16N4O4Couleur et forme :Off-WhiteMasse moléculaire :268.27(S)-Tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetic Acid
CAS :Produit contrôléFormule :C9H16N2O3Couleur et forme :NeatMasse moléculaire :200.23Sacubitril Sodium Salt
CAS :Formule :C24H28NO5·NaCouleur et forme :White To Off-WhiteMasse moléculaire :433.473Glecaprevir
CAS :Produit contrôléApplications Glecaprevir is an antiviral drug used in the treatment of patients with hepatitis C virus (HCV) genotype 1-6, of special interest for the treatment of patients with chronic kidney disease also suffering from HCV.
References Kwo, P., et. al.: J. Hepatol, 67, 263 (2017)Gane, E., et. al.: N. Engl. J. Med, 377, 1448 (2017)Formule :C38H46F4N6O9SCouleur et forme :NeatMasse moléculaire :838.86Bortezomib-D8 (Major)
CAS :Produit contrôléApplications Labelled Bortezomib, which the first proteasome inhibitor to be approved by the US FDA for multiple myeloma, a blood cancer. A reversible inhibitor of the 26S proteasome-a barrel-shaped multiprotein particle found in the nucleus and cytosol of all eukaryotic cells.d6-3%d7-10%d8-86%
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Nawrocki, S.T., et al: Cancer Research, 65, 11510 (2005)Formule :C19H17D8BN4O4Couleur et forme :Off-WhiteMasse moléculaire :392.29(2S,4S)-Sacubitril
CAS :Stability Moisture Sensitive
Applications (2S,4S)-Sacubitril is an impurity of Sacubitril (S080895) which is an antihypertensive drug used in combination with valsartan.
References McMurray, J., et al.: N. Eng. J. Med., 371 (2014);Formule :C24H29NO5Couleur et forme :NeatMasse moléculaire :411.49N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide
CAS :Impurity Bortezomib USP Impurity B
Applications N-[(1S)-2-Amino-2-oxo-1-(phenylmethyl)ethyl]-2-pyrazinecarboxamide is a metabolite of Bortezomib (B675700), a proteasome inhibitor for the treatment of multiple myeloma and is known to also target the ubiquitin-proteasome pathway.
References Pekol, T., et al.: Drug. Meta. Disp., 33, 771 (2005); Hsieh, F.Y., et al.: J. Pharma. Biomed. Anal., 49, 115 (2009);Formule :C14H14N4O2Couleur et forme :NeatMasse moléculaire :270.29Tabimorelin
CAS :Produit contrôléApplications NN703 (Tabimorelin) is an orally active growth hormone (GH) secretagogue intended for use as an alternative to daily injections of GH. In vitro studies in human liver microsomes have indicated that NN703 is a mechanism-based inhibitor of CYP3A4.
References Fabre, G., et al.: Biochem. Pharmacol., 37, 4389 (1988), Thummel, K., et al.: Clin. Pharmacol. Ther., 59, 491 (1996), Yu, D., et al.: J. Clin. Pharmacol., 39, 1203 (1999),Formule :C32H40N4O3Couleur et forme :NeatMasse moléculaire :528.68Sacubitril
CAS :Formule :C24H29NO5Couleur et forme :Off-White To Light YellowMasse moléculaire :411.49Semaglutide Impurity 54 (D-Ala 18)
D-Ala(18)-Semaglutide is a semaglutide impurity. The amino acid at position 18 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molDes-Glu(3)-Semaglutide
Des-Glu(3)-semaglutide is a semaglutide-related impurity. This des-amino acid form has got the glutamic acid or glutamate (Glu) amino acid from position 3 removed from the peptide chain. Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist used for managing type 2 diabetes and obesity.Formule :C182H284N44O56Masse moléculaire :3,984.53 g/molD-Ala(24)-Semaglutide
D-Ala(24)-Semaglutide is a semaglutide impurity. The amino acid at position 24 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/mol(S,E)-N-(1-(3-Methylbut-1-enylamino)-1-oxo-3-phenylpropan-2-yl)pyrazine-2-carboxamide
CAS :R-N-(1-(3-methylbut-1-enyl)-1-oxo-3-phenylpropan-2-yl) pyrazine-2-carboxamide is a drug product that is used for the treatment of bacterial infections. The compound is an impurity in the synthesis of other compounds and is also used as an analytical standard. It is synthesized from commercially available starting materials and through custom synthesis. R-N-(1-(3-methylbut-1-enyl)-1--oxo--3--phenylpropan--2--yl)pyrazine--2--carboxamide has been shown to be metabolized by CYP450 enzymes, which are responsible for the metabolism of many drugs. R-(1-(3Methylbut 1Enylamino)-1Oxo 3Phenylpropan 2Yl)Pyrazine 2Carboxamide has not been evaluated as a drug product and therefore does notFormule :C19H22N4O2Degré de pureté :Min. 95%Masse moléculaire :338.4 g/molSemaglutide Impurity 60 (D-Arg 30)
D-Arg(30)-Semaglutide is a semaglutide impurity. The amino acid at position 30 has been replaced by the D-form of the amino acid D-arginine (D-Arg). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/mol3,3',5,5'-Tetraiodothyroformic acid
CAS :Cymit Quimicaetic beta-D-glucosiduronic acidFormule :C13H6I4O4Degré de pureté :Min. 95 Area-%Couleur et forme :Off-White PowderMasse moléculaire :733.8 g/molD-His(1)-Semaglutide
D-His(1)-Semaglutide is a semaglutide impurity. The amino acid at position 1 has been replaced by the D-form of the amino acid D-histidine (D-His). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molD-Ser-(12)-Semaglutide
D-Ser(12)-Semaglutide is a semaglutide impurity. The amino acid at position 12 has been replaced by the D-form of the amino acid D-serine (D-Ser). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molSemaglutide Impurity 29 (β-Asp-9)
Beta-Asp-(9)-Semaglutide is a semaglutide impurity. The amino acid at position 9 has been replaced by the beta-aspartic acid (also known as isoaspartic, isoAsp, β-Asp or beta-Asp). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molDes-His(1)-Semaglutide
Des-His(1)-semaglutide is a semaglutide-related impurity. This des-amino acid form has the histidine (His) amino acid from position 1 removed from the peptide chain. Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist used for managing type 2 diabetes and obesity.Formule :C181H284N42O58Masse moléculaire :3,976.5 g/molD-Ala-(19)-Semaglutide
D-Ala(19)-Semaglutide is a semaglutide impurity. The amino acid at position 19 has been replaced by the D-form of the amino acid D-alanine (D-Ala). Semaglutide impurities are structurally related compounds that arise during synthesis, purification, or storage of semaglutide, a long-acting GLP-1 receptor agonist for managing type 2 diabetes and obesity.Formule :C187H291N45O59Masse moléculaire :4,113.64 g/molLisinopril EP Impurity E
CAS :Lisinopril EP Impurity E is an impurity of lisinopril, which is a prescription drug used to treat high blood pressure. This impurity was found in a preparative high performance liquid chromatography (HPLC) and mass spectroscopy analysis of the drug. The molecular weight of Lisinopril EP Impurity E was determined to be 317.2 amu, which corresponds to the molecular formula C7H13NO2. The FT-IR spectrum showed that this impurity has an ammonium group at 1859 cm-1 and butanoic acid at 1647 cm-1.Formule :C21H31N3O5Degré de pureté :Min. 98 Area-%Couleur et forme :PowderMasse moléculaire :405.49 g/mol


